Advertisement

Selected markers of proliferation and apoptosis in the parathyroid lesions: a spatial visualization and quantification

  • Elzbieta Kaczmarek
  • Katarzyna Lacka
  • Przemyslaw Majewski
  • Pawel Trzeciak
  • Agnieszka Gorna
  • Donata Jarmolowska-Jurczyszyn
  • Andrzej Kluk
Original Paper

Abstract

The aim of the paper was to apply a method for quantitative assessment of proliferation and apoptosis markers, based on their 3D visualization, in cases of parathyroid adenoma and hyperplasia. Material was obtained from 49 patients (32 females and 17 males) with primary hyperparahyroidism. Quantitative immunohistochemistry studies of Ki-67, proliferating cell nuclear antigen (PCNA) and bcl-2 were performed on digital microscopy images with the use of 3D visualization. The use of spatial visualization method allowed us to perform objective quantitative assessment of the studied immunohistochemical markers. The average cell nuclear fraction of Ki67+ was 1.8% in hyperplasia and 1.9% in adenoma cases while 3.5% in the controls. The highest expression of PCNA was found in parathyroid hyperplasia (22.9%) and significantly decreased in adenoma (12.5%) and in the control group (16.8%). The lower expression of bcl-2 in hyperplasia cases (mean area fraction of 0.172 per 1 μm2, in contrast to 0.643 in adenomas and 0.648 in control) suggested that principal cells can be ready for apoptosis and may confirm the important role of bcl-2 protein in etiopathogenesis of hyperplasia of the parathyroid gland while PCNA might be a useful marker for differentiating adenoma from early hyperplasia in primary hyperparahyroidism cases.

Keywords

Hyperparathyroidism PCNA Ki-67 Bcl-2 Image analysis Morphometry 

References

  1. Abbona GC, Papotti M, Gasparri G et al (1995) Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining. Hum Pathol 26:135–138. doi: 10.1016/0046-8177(95)90028-4 PubMedCrossRefGoogle Scholar
  2. Alo PL, Mazzaferro VP, Eleuteri S, Serpieri D, Mangoni A, Botti C et al (1999) Immunohistochemical study of fatty acid synthase, Ki67, proliferating cell nuclear antigen, and p53 in hyperplastic parathyroids expression. Ann Diagn Pathol 3:287–293. doi: 10.1016/S1092-9134(99)80024-0 PubMedCrossRefGoogle Scholar
  3. Bland JM, Altman DG (1999) Measuring agreement in method comparison studies. Stat Methods Med Res 8:135–160. doi: 10.1191/096228099673819272 PubMedCrossRefGoogle Scholar
  4. Brandi ML, Falchetti A (2004) Genetics of primary hyperparathyroidism. Urol Int 72(Suppl 1):11–16. doi: 10.1159/000076584 PubMedCrossRefGoogle Scholar
  5. Dahab GM, Kheriza MM, El-Beltagi HM, Fouda A-MM, Sharaf El-Din OA (2004) Digital quantification of fibrosis in liver biopsy sections: description of a new method by Photoshop software. J Gastroenterol Hepatol 19(1):78–85PubMedCrossRefGoogle Scholar
  6. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188. doi: 10.1016/0197-2456(86)90046-2 PubMedCrossRefGoogle Scholar
  7. Diallo JS, Aldejmah A, Mouhim AF, Peant B, Fahmy MA, Koumakpayi IH et al (2007) NOXA and PUMA expression add to clinicalmarkers in predicting biochemical recurrence of prostate cancer patients in a survival tree model. Clin Cancer Res 13(23):7044–7052. doi: 10.1158/1078-0432.CCR-07-1224 PubMedCrossRefGoogle Scholar
  8. Endl E, Gerdes J (2000) The Ki-67 protein: fascinating forms and an unknown function. Exp Cell Res 257:231–237. doi: 10.1006/excr.2000.4888 PubMedCrossRefGoogle Scholar
  9. Grimelius L, DeLellis RA, Bondeson L, Akerstrom G, Arnold A, Franssila KO, Hendy GN, Dupuy D, Eng C (2004) Parathyroid adenoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) World Health Organization classification of tumors, pathology and genetics tumors of endocrine origin. International Agency for Research on Cancer Press, Lyon, France, pp 128–132Google Scholar
  10. Hadar TSJ, Yaniv E, Ram E, Shvili I, Koren R (2005) Expression of p53, Ki-67 and Bcl-2 in parathyroid adenoma and residual normal tissue. Pathol Oncol Res 11:45–49PubMedCrossRefGoogle Scholar
  11. Hertig A, Maruani G, Paillard M, Houillier P (2000) Primary hyperparathyroidism. Nephrologie 21:283–290PubMedGoogle Scholar
  12. Kaczmarek E, Strzelczyk R (2005) From two to three-dimensional visualisation of structures in light and confocal microscopy—applications for biomedical studies. In: Mendez-Vilas A, Labajos-Broncano L (eds) Current issues on multidisciplinary microscopy research and education. FORMATEX microscopy book series no. II. Formatex Research Centre, Badajoz, pp 289–295Google Scholar
  13. Karak AK, Sarkar C, Chumber S, Tandon N (1997) MIB-1 proliferative index in parathyroid adenoma & hyperplasia. Indian J Med Res 105:235–238PubMedGoogle Scholar
  14. Loda M, Lipman J, Cukor B, Bur M, Kwan P, DeLellis RA (1994) Nodular foci in parathyroid adenomas and hyperplasias: an immunohistochemical analysis of proliferative activity. Hum Pathol 25:1050–1056PubMedCrossRefGoogle Scholar
  15. Lehr HE, van der Loos CM, Teeling P, Gown AM (1999) Complete chromogen separation and analysis in double immunohistochemical stains using photoshop-based image analysis. J Histochem Cytochem 47:119–125PubMedGoogle Scholar
  16. Maga G, Hubscher U (2003) Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci 116:3051–3060PubMedCrossRefGoogle Scholar
  17. Naccarato AG, Marcocci C, Miccoli P, Bonadio AG, Cianferotti L, Vignali E, Cipollini G, Viacava P (1998) Bcl-2, p53 and MIB-1 expression in normal and neoplastic parathyroid tissues. J Endocrinol Invest 21:136–141PubMedGoogle Scholar
  18. Ohta K, Manabe T, Katagiri M, Harada T (1994) Expression of proliferating cell nuclear antigens in parathyroid glands of renal hyperparathyroidism. World J Surg 18:625–628PubMedCrossRefGoogle Scholar
  19. Saggiorato E, Bergero N, Volante M, Bacillo E, Rosas R, Gasparri G, Orlandi F, Papotti M (2006) Galectin-3 and Ki-67 expression in multiglandular parathyroid lesions. Am J Clin Pathol 126:59–66PubMedCrossRefGoogle Scholar
  20. Sont JK, de Boer WI, Annemarie W, van Schadewijk AM, Grunberg K, Han J, van Krieken JM, Hiemstra PS, Sterk PJ, The Asthma Management Project University of Leiden Study Group (2003) Fully automated assessment of inflammatory cell counts and cytokine expression in bronchial tissue. Am J Respir Crit Care Med 167:1496–1503PubMedCrossRefGoogle Scholar
  21. Stangl DK, Berry DA (2000) Meta-analysis in medicine and health policy. CRC Press, Boca Raton, FLGoogle Scholar
  22. Szende B, Arvai K, Petak I, Nagy K, Vegso G, Perner F (2006) Changes in gne expression in the course of proliferative processes in the parathyroid gland. Magy Onkol 50:137–140PubMedGoogle Scholar
  23. Wang W, Johansson H, Kvasnicka T et al (1996) Detection of apoptotic cells and expression of Ki-67 antigen, Bcl-2, p53 oncoproteins in human parathyroid adenoma. APMIS 104:789–796PubMedGoogle Scholar
  24. Yamaguchi S, Yachiku S, Morikawa M (1997) Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism. J Clin Endocrinol Metab 82:2681–2688PubMedCrossRefGoogle Scholar
  25. Zhang P, Duchambon P, Gogusev J, Nabarra B, Sarfati E, Bourdeau A, Drüeke TB (2000) Apoptosis in parathyroid hyperplasia of patients with primary or secondary uremic hyperparathyroidism. Kidney Int 57:437–445PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • Elzbieta Kaczmarek
    • 1
  • Katarzyna Lacka
    • 2
  • Przemyslaw Majewski
    • 1
  • Pawel Trzeciak
    • 1
  • Agnieszka Gorna
    • 1
  • Donata Jarmolowska-Jurczyszyn
    • 1
  • Andrzej Kluk
    • 1
  1. 1.Department of PathomorphologyUniversity of Medical Sciences in PoznanPoznanPoland
  2. 2.Department of EndocrinologyUniversity of Medical Sciences in PoznanPoznanPoland

Personalised recommendations